Search

Your search keyword '"Morgan AG"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Morgan AG" Remove constraint Author: "Morgan AG"
175 results on '"Morgan AG"'

Search Results

1. Nasal myiasis in myasthenic crisis, a case report and literature review

3. The Role of Stenting in Management of Isolated Symptomatic Basilar Artery Stenosis

5. The effect of long, slow haemodialysis on patient survival.

6. Serum urate concentrations in homozygous sickle cell disease.

7. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis

8. Novel C3 Nephritic Factor Activity in the Glomerulonephritis of Staphylococcal Endocarditis

9. Both Patients and Plastic Surgeons Prefer Artificial Intelligence-Generated Microsurgical Information.

10. A Review of Radiation-Induced Vascular Injury and Clinical Impact.

11. Understanding the Role of Adipocytes and Fibroblasts in Cancer.

12. The Impact of the Dobbs Decision on Diagnostic Radiology Applicants, Residents, and Program Directors.

13. Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study.

14. Repeatability and comparison of 2D and 4D flow MRI measurement of intracranial blood flow and pulsatility in healthy individuals and patients with cerebral small vessel disease.

15. The effects of mechanical force on fibroblast behavior in cutaneous injury.

16. Development of Improved DNA Collection and Extraction Methods for Handled Documents.

19. Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3.

20. 4D flow MRI for non-invasive measurement of blood flow in the brain: A systematic review.

21. Relationship Between Venules and Perivascular Spaces in Sporadic Small Vessel Diseases.

22. Myeloperoxidase-mediated oxidation of edaravone produces an apparent non-toxic free radical metabolite and modulates hydrogen peroxide-mediated cytotoxicity in HL-60 cells.

23. Procedural Challenges During Intubation in Patients With Oropharyngeal Masses: A Prospective Observational Study.

24. Eosinophil peroxidase oxidizes isoniazid to form the active metabolite against M. tuberculosis, isoniazid-NAD .

25. Isoniazid induces a monocytic-like phenotype in HL-60 cells.

26. Extending the concept of weighted CT dose index to elliptical phantoms of various aspect ratios.

27. Analysis of uncertainties in Monte Carlo simulated organ and effective dose in chest CT: scanner- and scan-related factors.

28. Children's experiences of dental anxiety.

29. Restoring cortical control of functional movement in a human with quadriplegia.

30. Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites.

31. Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells.

32. An Overview of Preformed Metal Crowns. Part 2: The Hall Technique.

33. Adult abdomen-pelvis CT: Does equilibrium dose-pitch product better account for the kVp dependence of organ dose than conventional CTDI?

34. Why, what and how: caries control for erupting molars.

35. Acceptability of fissure sealants from the child's perspective.

36. Impact of the Hall technique for preformed metal crown placement on undergraduate paediatric dentistry experience.

37. Child and parental acceptance of preformed metal crowns.

38. The case report in 21st century child dental literature.

39. Ectopic eruption of first permanent molars: presenting features and associations.

40. Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

41. Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination.

42. Gender and age differences in plasma carnitine, muscle strength, and exercise tolerance in haemodialysis patients.

43. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.

44. Impaired bacterial killing and hydrogen peroxide production by polymorphonuclear neutrophils in end-stage renal failure.

45. A prospective study of ward referrals for renal disease at a Jamaican and a United Kingdom hospital.

46. Hydrogen peroxide generation by polymorphonuclear leukocytes exposed to peritoneal dialysis effluent.

47. Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.

48. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.

49. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.

50. The management of acute renal failure.

Catalog

Books, media, physical & digital resources